Viatris Inc.

VTRS · Healthcare

About Viatris Inc.

Viatris Inc. (VTRS) has been publicly traded since 1980, making it a 46-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Canonsburg, United States and employs approximately 30,000 people. With a market capitalization of $16 billion, VTRS is a large established company.

Key Statistics

Current Price
$13.51
Market Cap
$15.56B
52-Week High
$16.47
52-Week Low
$6.85
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

$1,000 Invested

1 Year
$1,575
+57%
3 Years
$1,526
+53%
5 Years
$1,198
+20%
10 Years
$361
+-64%
Since IPO
$13,455
+1245%

Monthly Returns Heatmap

Annual Returns

Avg Return
+12.88%
Best Year
1989 (+175.12%)
Worst Year
1986 (-39.18%)
Positive Years
28/46
Year Return Start End
2026 +9.44% $12.34 $13.51
2025 +5.08% $11.75 $12.34
2024 +19.68% $9.82 $11.75
2023 +2.06% $9.62 $9.82
2022 -14.29% $11.22 $9.62
2021 -26.12% $15.19 $11.22
2020 -6.77% $16.29 $15.19
2019 -26.64% $22.21 $16.29
2018 -35.24% $34.29 $22.21
2017 +10.90% $30.92 $34.29
2016 -29.44% $43.82 $30.92
2015 -4.08% $45.69 $43.82
2014 +29.88% $35.18 $45.69
2013 +58.11% $22.25 $35.18
2012 +27.91% $17.39 $22.25
2011 +1.56% $17.13 $17.39
2010 +14.65% $14.94 $17.13
2009 +86.35% $8.02 $14.94
2008 -29.66% $11.40 $8.02
2007 -29.13% $16.08 $11.40
2006 +1.15% $15.90 $16.08
2005 +14.17% $13.92 $15.90
2004 -29.58% $19.77 $13.92
2003 +63.53% $12.09 $19.77
2002 -6.43% $12.92 $12.09
2001 +49.71% $8.63 $12.92
2000 +0.69% $8.57 $8.63
1999 -19.48% $10.65 $8.57
1998 +51.31% $7.04 $10.65
1997 +27.08% $5.54 $7.04
1996 -28.62% $7.76 $5.54
1995 +31.44% $5.90 $7.76
1994 +7.29% $5.50 $5.90
1993 -19.02% $6.79 $5.50
1992 +52.08% $4.47 $6.79
1991 +103.20% $2.20 $4.47
1990 -14.32% $2.57 $2.20
1989 +175.12% $0.93 $2.57
1988 +8.30% $0.86 $0.93
1987 -25.19% $1.15 $0.86
1986 -39.18% $1.89 $1.15
1985 -27.59% $2.61 $1.89
1984 +27.67% $2.05 $2.61
1983 +10.42% $1.85 $2.05
1982 +6.67% $1.74 $1.85
1981 +107.69% $0.84 $1.74

Valuation

The forward P/E ratio is 5.1. The price-to-book ratio stands at 1.1. The price-to-sales ratio is 1.1.

Dividends

Viatris Inc. pays a dividend to shareholders with a current yield of 3.56%. This translates to $0.48 per share annually. The payout ratio of 10% indicates sustainable dividend coverage.

Risk & Volatility

VTRS has a beta of 0.80, indicating it is less volatile than the overall market. The stock's 52-week range is $6.85 to $16.47, and it currently trades in the upper half of its 52-week range.

Analyst Ratings

Based on 9 analyst opinions, VTRS has a consensus "buy" rating. The average price target of $15.50 suggests 14.7% upside from current levels.

Frequently Asked Questions

What does Viatris Inc. do?

Viatris Inc. is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Canonsburg, United States.

What sector is VTRS in?

VTRS operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

When did VTRS go public?

Viatris Inc. went public in 1980, making it a 46-year-old public company as of 2026.

How much would $1,000 invested in VTRS 5 years ago be worth today?

A $1,000 investment in VTRS five years ago would be worth approximately $1,198 today, representing a 19.8% return.

Does VTRS pay dividends?

Yes, Viatris Inc. pays a dividend with a current yield of 3.56%, which is $0.48 per share annually.

What is VTRS's market cap?

Viatris Inc. has a market capitalization of $16 billion, classifying it as a large-cap company.

Is VTRS a buy, hold, or sell?

Based on 9 opinions, VTRS has a consensus "buy" rating. The average price target is $15.5.

Last updated: 3/14/2026